| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.004 |